A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor ...
Progressing first-in-class, tissue-tethered autoimmune platform – Type 1 diabetes candidate on track for CTA submission in 2025; first universal candidate targeting CD1a initially for atopic ...
SAN CARLOS, CA and FORT WORTH, TX / ACCESSWIRE / January 9, 2025 / CAGE Bio, Inc., a clinical-stage biotechnology company advancing innovative therapies for high incidence immuno-dermatological ...
MUI KITCHEN US (English) on MSN3d
These Are the Top 10 Foods That Cause the Most DermatitisWatch out for these foods—they could trigger allergic reactions on your skin and cause various other discomforts.
From atopic dermatitis to contact dermatitis, discover expert-backed treatments and lifestyle changes that can help manage ...
Technoderma Medicines, Inc. ('the Company'), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback